Early 24-hour blood pressure response to Roux-en-Y gastric bypass in obese patients

References

• Masuo K, Mikami H, Ogihara T, Tuck ML. Weight gain-induced blood pressure elevation. Hypertension 2000;35:1135–40.
   PubMed Web of Science ®Google Scholar
• Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol 2004;286:R803–13.
   PubMed Web of Science ®Google Scholar
• Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V. Body mass index, abdominal adiposity and blood pressure: consistency of their association across developing and developed countries. Int J Obes Relat Metab Disord J Int Assoc Study Obes 2002;26:48–57.
   PubMed Web of Science ®Google Scholar
• Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002;106:2533–6.
   PubMed Web of Science ®Google Scholar
• Davy KP. The global epidemic of obesity: are we becoming more sympathetic? Curr Hypertens Rep 2004;6:241–6.
   PubMed Web of Science ®Google Scholar
• Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010;23:1170–8.
   PubMed Web of Science ®Google Scholar
• Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft C, Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005;45:356–62.
   PubMed Web of Science ®Google Scholar
• Adams ST, Salhab M, Hussain ZI, Miller GV, Leveson SH. Obesity-related hypertension and its remission following gastric bypass surgery: a review of the mechanisms and predictive factors. Blood Press 2012;22:131–7.
   PubMed Web of Science ®Google Scholar
• Rahmouni K. Leptin-induced sympathetic nerve activation: signaling mechanisms and cardiovascular consequences in obesity. Curr Hypertens Rev 2010;6:104–209.
   PubMedGoogle Scholar
• Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH, de Lemos JA. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005;112:2163–8.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PWF, Vasa R. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594–600.
   PubMed Web of Science ®Google Scholar
• Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities – the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;334:374–82.
   PubMed Web of Science ®Google Scholar
• Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 2013;273:219–34.
   PubMed Web of Science ®Google Scholar
• Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, Ahlin S, Anveden Å, Bengtsson C, Bergmark G. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56–65.
   PubMed Web of Science ®Google Scholar
• Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Shoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37.
   PubMed Web of Science ®Google Scholar
• Sjöström L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351:2683–93.
   PubMed Web of Science ®Google Scholar
• Hallersund P, Sjöström L, Olbers T, Lönroth H, Jacobson P, Wallenius V, Näslund I, Carlsson LM, Fändriks L. Gastric bypass surgery is followed by lowered blood pressure and increased diuresis: long term results from the Swedish Obese Subjects (SOS) study. PLoS One 2012;7:e49696
   PubMed Web of Science ®Google Scholar
• Frezza EE, Wei C, Wachtel MS. Is surgery the next answer to treat obesity-related hypertension? J Clin Hypertens (Greenwich) 2009;11:284–8.
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Goldman CD, Ho HS, Gosselin RC, Singh A, Wolfe BM. Systemic stress response after laparoscopic and open gastric bypass. J Am Coll Surg 2002;194:557–66.
   PubMed Web of Science ®Google Scholar
• Ahmed AR, Rickards G, Coniglio D, Xia Y, Johnson J, Boss T, O’Malley W. Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure. Obes Surg 2009;19:845–9.
   PubMed Web of Science ®Google Scholar
• Hinojosa MW, Varela JE, Smith BR, Che F, Nguyen NT. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg off J Soc Surg Aliment Tract 2009;13:793–7.
   PubMed Web of Science ®Google Scholar
• Bonfils PK, Taskiran M, Damgaard M, Goetze JP, Floyd AK, Funch-Jensen P, Kristiansen VB, Støckel M, Bouchelouche PN, Gadsbøll N. Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients. J Hypertens 2015;33:1215–25.
   PubMed Web of Science ®Google Scholar
• Wasmund SL, Yanowitz FG, Adams TD, Hunt SC, Hamdan MH, Litwin SE. Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm off J Heart Rhythm Soc 2011;8:84–90.
   PubMed Web of Science ®Google Scholar
• Lind L, Zethelius B, Sundbom M, Edén Engström B, Karlsson FA. Vasoreactivity is rapidly improved in obese subjects after gastric bypass surgery. Int J Obes (Lond) 2009;33:1390–5.
   PubMed Web of Science ®Google Scholar
• Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshi N, Lee H, Yapp K, Olivan B. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008;93:2479–85.
   PubMed Web of Science ®Google Scholar
• Rhee NA, Vilsbøll T, Knop FK. Current evidence for a role of GLP-1 in Roux-en-Y gastric bypass-induced remission of type 2 diabetes. Diabetes Obes Metab 2012;14:291–8.
   PubMed Web of Science ®Google Scholar
• Le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, Lönroth H, Fändriks L, Ghatei M, Bloom SR, Olbers T. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007;246:780–5.
   PubMed Web of Science ®Google Scholar
• Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005;15:474–81.
   PubMed Web of Science ®Google Scholar
• Skov J, Holst JJ, Gøtze JP, Frøkiær J, Christiansen JS. Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males. Endocr Connect 2014;3:11–6.
   PubMed Web of Science ®Google Scholar
• Gutzwiller J-P, Tschopp S, Bock A, Zehnder CE, Huber AR, Kreyenbuehl M, Gutmann H, Drewe J, Henzen C, Goeke B, Beglinger C. Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men. J Clin Endocrinol Metab 2004;89:3055–61.
   PubMed Web of Science ®Google Scholar
• Sullivan CA, Kahn SE, Fujimoto WY, Hayashi T, Leonetti DL, Boyko EJ. Change in intra-abdominal fat predicts the risk of hypertension in Japanese Americans. Hypertension 2015;66:134–40.
   PubMed Web of Science ®Google Scholar
• Després J-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012;126:1301–13.
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821–30.
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, Vega GL, Khera A, McGuire D, Grundy SM, de Lemos JA. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring Md) 2013;21:E439–47.
   PubMed Web of Science ®Google Scholar
• Bloomfield GL, Sugerman HJ, Blocher CR, Gehr TW, Sica DA. Chronically increased intra-abdominal pressure produces systemic hypertension in dogs. Int J Obes Relat Metab Disord J Int Assoc Study Obes 2000;24:819–24.
   PubMed Web of Science ®Google Scholar
• Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ. Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels. J Trauma 1997;42:997–1004; discussion 1004–5.
   PubMed Web of Science ®Google Scholar